Focusing on glucose metabolism, the glycolytic metabolite phosphoenolpyruvic acid (PEP) can influence the activity of tumor-infiltrating lymphocytes (TILs), and enzymes such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) serve as metabolic checkpoint regulators. The gene discussed is GAPDH; the disease is neoplasm.